{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:16:59Z","timestamp":1790043419072,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011512","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A6A3A11934276"],"award-info":[{"award-number":["2016R1A6A3A11934276"]}],"id":[{"id":"10.13039\/100011512","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijantimicag.2019.05.022","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T22:18:41Z","timestamp":1559686721000},"page":"154-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption"],"prefix":"10.1016","volume":"54","author":[{"given":"Mi-Ran","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4143-035X","authenticated-orcid":false,"given":"Hyunjoo","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0001","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/CMR.00082-09","article-title":"The changing epidemiology of Clostridium difficile infections","volume":"23","author":"Freeman","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0002","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s15010-007-6113-0","article-title":"Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance","volume":"35","author":"Razavi","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0003","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cmi.2014.09.017","article-title":"Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes","volume":"21","author":"Freeman","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0004","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile","volume":"353","author":"McDonald","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1469-0691.2012.03910.x","article-title":"Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea","volume":"19","author":"Kim","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0006","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkh285","article-title":"Long-term surveillance of cefotaxime and piperacillin\u2013tazobactam prescribing and incidence of Clostridium difficile diarrhoea","volume":"54","author":"Wilcox","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0007","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/cid\/cix379","article-title":"The effect of a piperacillin\/tazobactam shortage on antimicrobial prescribing and Clostridium difficile risk in 88 US medical centers","volume":"65","author":"Gross","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0008","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/48.5.741","article-title":"Reduced susceptibility of Clostridium difficile to metronidazole","volume":"48","author":"Brazier","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0009","series-title":"2012 Annual Meeting of the Korean Society of Infectious Disease and the Korean Society for Chemotherapy; 1\u20132 September 2012","first-page":"179","article-title":"Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB and binary toxin genes","author":"Seo","year":"2012"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0010","series-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria","year":"2007"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0011","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1, 2017. http:\/\/www.eucast.org\/ [accessed 19 November 2018]."},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0012","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.00342-08","article-title":"Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile","volume":"52","author":"O'Connor","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0013","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1099\/jmm.0.028571-0","article-title":"Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile","volume":"60","author":"Huhulescu","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0014","unstructured":"World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. Definition and general considerations. The basic definition of the defined daily dose (DDD). Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology. http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/ [Accessed 19 November 2018]."},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0015","series-title":"6th International Clostridium difficile Symposium (ICDS); 12\u201314 September 2018","first-page":"37","article-title":"Decrypting plasmids: stable metronidazole resistance in Clostridium difficile correlates with a plasmid","author":"Boekhoud","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0016","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12879-016-1514-2","article-title":"Do piperacillin\/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?","volume":"16","author":"Kundrapu","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-14-29","article-title":"Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin\/tazobactam","volume":"14","author":"Garneau","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0018","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1128\/AAC.48.11.4427-4429.2004","article-title":"Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci","volume":"48","author":"Currie","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.05.022_bib0019","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ijantimicag.2018.01.025","article-title":"Prevalence, genetic relatedness and antibiotic resistance of hospital-acquired Clostridium difficile PCR ribotype 018 strains","volume":"51","author":"Seo","year":"2018","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:33:00Z","timestamp":1760376780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919301396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0924857919301396"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.05.022","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}